Boehringer Ingelheim Roxane Inc recalls Oxcarbazepine Oral Suspension, 300 mg/5 mL, 250 mL bottle, Rx only, Boehringer Ingelheim, Roxane Laboratories, Inc. Colu
Recalled November 27, 2013 · FDA recall D-002-2014 · Boehringer Ingelheim Roxane
Hazard
Resuspension Problems: Recalled lot did not meet resuspendability requirements. · FDA Class II
Units
10,267 bottles
Sold at
Nationwide
Description
Resuspension Problems: Recalled lot did not meet resuspendability requirements.
Product
Oxcarbazepine Oral Suspension, 300 mg/5 mL, 250 mL bottle, Rx only, Boehringer Ingelheim, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC 0054-0199-59
Manufacturer(s)
Boehringer Ingelheim Roxane Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →